Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer

Gynecologic Oncology

Volumn 126, Issue 1, 2012, Pages 58-63

  Tanner, Edward J ^a   Long, Kara C ^a   Zhou, Qin ^a   Brightwell, Rachel M ^a   Gardner, Ginger J ^a   Abu Rustum, Nadeem R ^a   Leitao Jr , Mario M ^a   Sonoda, Yukio ^a   Barakat, Richard R ^a   Iasonos, Alexia ^a   Chi, Dennis S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Advanced ovarian cancer; Cytoreductive surgery; Operative start time

Indexed keywords

ALBUMIN; CA 125 ANTIGEN;

ABDOMINAL DISEASE; ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES; CANCER PATIENT; CANCER STAGING; CARCINOMATOSIS; COHORT ANALYSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPERATION DURATION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGEON; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CYSTADENOCARCINOMA, SEROUS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862769565     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.04.014     Document Type: Article

References (27)

1. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975;42:101-4.
2. Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-9 discussion 979-980.
3. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 1999;72:278-87. (Pubitemid 29118182)
4. Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev 2011(8):CD007565.
5. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 2009;115:1234-44.
6. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998;69:103-8. (Pubitemid 28246994)
7. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006;103:559-64. (Pubitemid 44602167)
8. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 2006;103:1083-90. (Pubitemid 44821338)
9. Magtibay PM, Adams PB, Silverman MB, Cha SS, Podratz KC. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 2006;102:369-74. (Pubitemid 44041661)
10. Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, et al. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol 2006;103:977-84. (Pubitemid 44834356)
11. Eastridge BJ, Hamilton EC, O'Keefe GE, Rege RV, Valentine RJ, Jones DJ, et al. Effect of sleep deprivation on the performance of simulated laparoscopic surgical skill. Am J Surg 2003;186:169-74. (Pubitemid 37289092)
12. Halldorson JB, BakthavatsalamR, Reyes JD, Perkins JD. The impact of consecutive operations on survival after liver transplantation. Liver Transpl 2009;15:907-14.
13. Morrison CA, Wyatt MM, Carrick MM. Impact of the 80-hour work week on mortality and morbidity in trauma patients: an analysis of the National Trauma Data Bank. J Surg Res 2009;154:157-62.
14. Taffinder NJ, McManus IC, Gul Y, Russell RC, Darzi A. Effect of sleep deprivation on surgeons' dexterity on laparoscopy simulator. Lancet 1998;352:1191. (Pubitemid 28458536)
15. Wesnes KA, Walker MB, Walker LG, Heys SD, White L, Warren R, et al. Cognitive performance and mood after a weekend on call in a surgical unit. Br J Surg 1997;84:493-5. (Pubitemid 27196288)
16. Wu AW, Folkman S, McPhee SJ, Lo B. Do house officers learn from their mistakes? JAMA 1991;265:2089-94.
17. Yaghoubian A, Kaji AH, Ishaque B, Park J, Rosing DK, Lee S, et al. Acute care surgery performed by sleep deprived residents: are outcomes affected? J Surg Res 2010;163:192-6.
18. Chacko AT, Ramirez MA, Ramappa AJ, Richardson LC, Appleton PT, Rodriguez EK. Does late night hip surgery affect outcome? J Trauma 2011;71:447-53.
19. George TJ, Arnaoutakis GJ, Merlo CA, Kemp CD, Baumgartner WA, Conte JV, et al. Association of operative time of day with outcomes after thoracic organ transplant. JAMA 2011;305:2193-9.
20. Kelz RR, Freeman KM, Hosokawa PW, Asch DA, Spitz FR, Moskowitz M, et al. Time of day is associated with postoperative morbidity: an analysis of the national surgical quality improvement program data. Ann Surg 2008;247: 544-52.
21. Kelz RR, Tran TT, Hosokawa P, HendersonW, Paulson EC, Spitz F, et al. Time-of-day effects on surgical outcomes in the private sector: a retrospective cohort study. J Am Coll Surg 2009;209:434-45 e2.
22. Tan PJ, Xu M, Sessler DI, Bashour CA. Operation timing does not affect outcome after coronary artery bypass graft surgery. Anesthesiology 2009;111:785-9.
23. Wright MC, Phillips-Bute B, Mark JB, Stafford-Smith M, Grichnik KP, Andregg BC, et al. Time of day effects on the incidence of anesthetic adverse events. Qual Saf Health Care 2006;15:258-63.
24. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope RC, Wilshon TO, et al. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. J Am Coll Surg 2009;208:614-20.
25. Zivanovic O, Sima CS, Iasonos A, Hoskins WJ, Pingle PR, Leitao Jr MM, et al. The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. Gynecol Oncol 2010;116:351-7.
26. Hamilton CA, Miller A, Miller C, Krivak TC, Farley JH, Chernofsky MR, et al. The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a gynecologic oncology group study. Gynecol Oncol 2011;122:521-6.
27. Ibeanu OA, Bristow RE. Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review. Int J Gynecol Cancer 2010;20(Suppl. 1):S1-S11.